L-Quebrachitol Attenuates RANKL-Induced Osteoclastogenesis and Bone Resorption in Ovariectomized Rat Model

Area of Science:

• Biochemistry
• Cell Biology
• Bone Biology

Background:

• Inositol and its methyl derivatives exhibit diverse biological activities.
• L-quebrachitol, a methyl derivative of inositol, promotes osteoblastogenesis and bone formation.
• The effect of L-quebrachitol on osteoclastogenesis, crucial for bone resorption, is not well understood.

Purpose of the Study:

• To investigate the inhibitory effect of L-quebrachitol on osteoclastogenesis.
• To elucidate the molecular mechanisms underlying L-quebrachitol's action on osteoclast differentiation.
• To evaluate L-quebrachitol's efficacy in preventing bone loss in an animal model of osteoporosis.

Main Methods:

• In vitro studies using pre-osteoclastic RAW 264.7 cells stimulated with receptor activator of nuclear factor-κB ligand (RANKL).
• Analysis of key signaling pathways including nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and Fos proto-oncogene (cFOS).
• Assessment of osteoclast-associated marker genes (TRAP, MMP-9, cathepsin K) and proteasome subunit alpha type-5 (PSMA5).
• In vivo studies using an ovariectomized rat model to assess bone microarchitecture.

Main Results:

• L-quebrachitol suppressed RANK-mediated signaling pathways (NF-κB, cFOS) at both gene and protein levels.
• Downregulation of nuclear factor of activated T cells c1 (NFATc1), a key transcription factor for osteoclastogenesis.
• Reduced expression of osteoclast-associated genes (TRAP, MMP-9, cathepsin K) led to decreased multinucleated cell formation and resorption pits.
• L-quebrachitol suppressed PSMA5, involved in NF-κB inhibitor degradation.
• In ovariectomized rats, L-quebrachitol increased bone volume/total volume (BV/TV) and trabecular thickness (Tb.Th).

Conclusions:

• L-quebrachitol exhibits a dose-dependent inhibitory effect on osteoclastogenesis.
• The compound modulates RANK-mediated signaling pathways, offering a potential therapeutic strategy for osteoporosis.
• L-quebrachitol demonstrates bone homeostasis properties by preventing bone loss in an animal model.
• Further research is warranted to explore L-quebrachitol's full potential for osteoporosis treatment.